Table 1. Baseline clinicopathologic features of 151 male breast cancers.

Characteristics	All cases (n = 151)	Characteristics	All cases (n = 151)
Age (mean), years	66 (n = 150)	Histological grade
</ = 50	15 (10%)	I	38 (25.2%)
>50	135 (90%)	II	66 (43.7%)
		III	47 (31.1%)
Histological type
Ductal	136 (90%)	Lymph node metastasis	n = 124
Lobular	3 (2%)	Absent	56 (45.2%)
Invasive cribriform	3 (2%)	Present	68 (54.8%)
Mixed (ductal/lobular)	3 (2%)
Mucinous	2 (1.3%)	Immunohistochemistry
Papillary	2 (1.3%)	ER	n = 150
Invasive micropapillary	1 (0.7%)	(+)	135 (90%)
Adenoid cystic	1 (0.7%)	(−)	15 (10%)
Tumor size (mean), cm	2.235 (n = 147)	PR	n = 150
T1	79 (54.1)	(+)	99 (66%)
T2	64 (43.5%)	(−)	51 (34%)
T3	4 (2.7%)
		AR	n = 150
Tubule formation		(+)	120 (80%)
>75%	14 (9.3%)	(−)	30 (20%)
10–75%	59 (39.1%)
<10%	78 (51.7%)	HER2	n = 150
		(+)	5 (3.3%)
Nuclear atypia		(−)	145 (96.7%)
Mild	13 (8.6%)
Moderate	89 (58.9%)	Bcl2 (10%)	n = 149
Severe	49 (32.5%)	(+)	140 (94%)
		(−)	9 (6%)
Mitotic activity index/2 mm2
<8 mitoses	60 (49.7%)	Bcl2 (30%)	n = 149
8–14 mitoses	40 (26.5%)	(+)	137 (92%)
15 or>mitoses	51 (33.8%)	(−)	12 (8%)